DoW Pancreatic Cancer Research Program, Translational Research Partnership Award
This grant funds research partnerships focused on pancreatic cancer.
About this program
The DoW Pancreatic Cancer Research Program offers the Translational Research Partnership Award to support collaborative research efforts aimed at advancing the understanding and treatment of pancreatic cancer. This program is designed for research institutions and organizations that are committed to innovative approaches in pancreatic cancer research. The goal is to foster partnerships that can translate scientific discoveries into clinical applications, ultimately improving patient outcomes. Eligible applicants include academic institutions, nonprofit organizations, and other entities engaged in cancer research. The program encourages multidisciplinary collaborations that bring together expertise from various fields to tackle the complexities of pancreatic cancer. By providing funding for these partnerships, the program aims to accelerate the pace of research and facilitate the development of new therapies and diagnostic tools for this challenging disease.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other entities engaged in cancer research.